United States Insulin Delivery Market Outlook to 2033 - Insulin Pens and Insulin Pumps

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Insulin Delivery Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Insulin Delivery Market, United States, Revenue ($m), 2018-2033
3.1.1 Insulin Pens Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Insulin Delivery Market, United States, Volume (Units), 2018-2033
3.2.1 Insulin Pens Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Insulin Pumps Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Insulin Delivery Market, United States, Average Price ($), 2018-2033
3.4 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2025

4.1 Novo Nordisk AS
4.1.1 Company Overview
4.2 Eli Lilly and Co
4.2.1 Company Overview
4.3 Insulet Corp
4.3.1 Company Overview
4.4 Sanofi
4.4.1 Company Overview
4.5 Medtronic Plc
4.5.1 Company Overview
4.6 Tandem Diabetes Care Inc
4.6.1 Company Overview

6.1 Corporate Communications
6.1.1 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work
6.1.2 Nov 21, 2025: Stroke Prevention Study CREST-2 Stenting
6.1.3 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors
6.1.4 Nov 17, 2025: Embecta Announces Changes to Board of Directors
6.1.5 Nov 05, 2025: Genesys Strike Negotiations Update
6.1.6 Oct 24, 2025: Payman Khales Becomes Integer President and CEO
6.1.7 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme
6.1.8 Oct 07, 2025: Tidepool Joins Milken Institute’s Women’s Health Network as Inaugural Member
6.1.9 Sep 29, 2025: MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
6.1.10 Sep 25, 2025: Joe Hedges Appointed New Associate Director of David G. Pollart Center for Arts and Humanities
6.1.11 Sep 16, 2025: Insulet Announces CFO Appointment
6.1.12 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
6.1.13 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
6.1.14 Apr 28, 2025: Insulet Appoints Ashley McEvoy President and CEO
6.1.15 Jan 06, 2025: MannKind Expands Executive Leadership Team
6.2 Financial Announcements
6.2.1 Nov 05, 2025: Fractyl Health to Report Third Quarter 2025 Financial Results and Business Updates
6.2.2 Oct 30, 2025: Lilly Reports Third-Quarter 2025 Financial Results, Highlights R&D Pipeline Momentum and Raises 2025 Guidance
6.2.3 Oct 09, 2025: Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
6.2.4 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
6.2.5 Aug 08, 2025: Embecta Announces Q3 Fiscal 2025 Results
6.2.6 Aug 07, 2025: Lilly Announces Q2 2025 Results and Raises Guidance
6.2.7 Aug 07, 2025: Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency)
6.2.8 Jul 24, 2025: Lilly Confirms Date and Conference Call for Second-Quarter 2025 Financial Results Announcement
6.2.9 Jul 24, 2025: Embecta to Report Fiscal Third Quarter 2025 Financial Results
6.2.10 Jul 09, 2025: Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
6.2.11 Apr 15, 2025: Johnson & Johnson Announces Q1 2025 Results
6.2.12 Mar 28, 2025: Retractable Technologies Announces Results for 2024
6.2.13 Feb 19, 2025: MannKind Corp to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
6.2.14 Jan 23, 2025: embecta to Report Fiscal First Quarter 2025 Financial Results
6.3 Government and Public Interest
6.3.1 Dec 01, 2025: Fractyl Health to Participate in 8th Annual Evercore Healthcare Conference
6.3.2 Nov 03, 2025: Beta Bionics Announces Participation at Upcoming Investor Conferences
6.3.3 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
6.3.4 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD
6.3.5 Aug 22, 2025: Lilly to Participate in Wells Fargo 20th Annual Healthcare Conference
6.3.6 Aug 21, 2025: Beta Bionics Announces Participation at Upcoming Investor Conferences
6.3.7 Aug 19, 2025: Insulet to Participate in Upcoming Investor Conferences
6.3.8 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
6.3.9 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
6.3.10 Apr 16, 2025: Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
6.3.11 Feb 13, 2025: Tandem Diabetes Care Announces Upcoming Conference Presentations
6.3.12 Feb 06, 2025: MannKind to Present at Upcoming Investor Conferences
6.3.13 Feb 03, 2025: Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference
6.3.14 Dec 12, 2024: Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
6.4 Other Significant Developments
6.4.1 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes
6.4.2 Apr 23, 2025: Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research
6.4.3 Feb 04, 2025: As Major Insulin Producers Shift Focus, Rbio Steps up To Address Potential Shortages
6.5 Product News
6.5.1 Nov 22, 2025: Insul-eze Syringe Magnifier 2x Magnification for Easy Viewing
6.5.2 Nov 20, 2025: Stanley Hsia, MD, Presents Phase 2 Trial Results for Mazdutide
6.5.3 Nov 20, 2025: University Hospitals Approved as U.S. Site and Only Ohio Site to Administer Lantidra for Type 1 Diabetes
6.5.4 Nov 13, 2025: Century Therapeutics Unveils Beta Islet Program for Type 1 Diabetes
6.5.5 Nov 10, 2025: Scientists Identify Trigger for Obesity-Linked Inflammation
6.5.6 Oct 13, 2025: MannKind Receives FDA Acceptance for Afrezza Application for Pediatric Diabetes Treatment
6.5.7 Oct 08, 2025: Ithaca Startup Seeks To Alleviate Daily Burden For Diabetes Patients
6.5.8 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment
6.5.9 Oct 03, 2025: Hong Kong Grants Precision Medicine Patent to Diamyd Medical for Insulin Antigen Treatment in Type 1 Diabetes
6.5.10 Sep 29, 2025: Novo Nordisk Resubmits Awiqli® to the FDA for Once-Weekly Basal Insulin for Type 2 Diabetes
6.5.11 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD
6.5.12 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes
6.5.13 Sep 09, 2025: Lilly Introduces TuneLab Platform To Enhance AI-Enabled Drug Discovery Access For Biotech Companies
6.5.14 Apr 01, 2025: Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations
6.6 Strategy And Business Planning
6.6.1 Oct 08, 2025: Enovis Completes Sale of Dr. Comfort Footcare Solutions Business for Up to $60 Million
6.6.2 Oct 07, 2025: Tidepool Joins Milken Institute’s Women’s Health Network as Inaugural Member
6.6.3 Sep 09, 2025: Lilly Introduces TuneLab Platform To Enhance AI-Enabled Drug Discovery Access For Biotech Companies

7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer

Table 1: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Insulin Delivery Market, United States, Volume (Units), 2018-2033
Table 5: Insulin Pens Market, United States, Volume (Units), 2018-2033
Table 6: Insulin Pumps Market, United States, Volume (Units), 2018-2033
Table 7: Insulin Delivery Market, United States, Average Price ($), 2018-2033
Table 8: Insulin Delivery Market, United States, Company Share by Revenue ($m), 2025
Table 9: Insulin Delivery Market Pipeline Products

Figure 1: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Insulin Delivery Market, United States, Volume (Units), 2018-2033
Figure 5: Insulin Pens Market, United States, Volume (Units), 2018-2033
Figure 6: Insulin Pumps Market, United States, Volume (Units), 2018-2033
Figure 7: Insulin Delivery Market, United States, Company Share (%), 2025